معرفی
Martin Turner is Professor of Clinical Neurology & Neuroscience at the University of Oxford's Nuffield Department of Clinical Neuroscience within the Medical Sciences Division. He serves as a Consultant Neurologist at John Radcliffe Hospital and is Associate Director of the Oxford University Clinical Academic Graduate School (OUCAGS). As a Senior Research Fellow at Green Templeton College, he plays a significant role in academic leadership and mentoring.
- MA (Cantab), MBBS, PhD, FRCP (Lond)
- Senior Research Fellow, Green Templeton College
- Associate Director, Oxford University Clinical Academic Graduate School
- Consultant Neurologist, John Radcliffe Hospital
- ORCID: 0000-0003-0267-3180
Professor Turner's research focuses on identifying biomarkers for amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND). His work spans from molecular studies to neural network analysis, using advanced techniques including MRI, MEG, proteomics, and extracellular vesicle extraction. He leads the Oxford Study for Biomarkers in MND (BioMOx), which investigates potential diagnostic and prognostic biomarkers through imaging and biofluid analysis. His groundbreaking work on neurofilament light chain as a blood-based biomarker earned his team the Sean M. Healey International Prize for Innovation in ALS in 2023. He also co-leads the £8m NIHR-funded EXPERTS-ALS initiative and directs the Families for the Treatment of Hereditary MND (FaTHoM) program and the C9ORF72 National Registry (ACORN).
His publication record reveals a consistent focus on ALS biomarker development, with recent work examining cerebrospinal fluid biomarkers, genetic factors in ALS/FTD, lipid metabolism in neurodegeneration, and neuroimaging techniques to track disease progression. His research increasingly integrates multi-modal approaches, combining neuroimaging with biochemical analysis to develop comprehensive biomarker panels.
Professor Turner has received significant recognition for his work, most notably the Sean M. Healey International Prize for Innovation in ALS in 2023. His leadership in the £8m NIHR-funded EXPERTS-ALS program demonstrates his standing as a major figure in international ALS research.
Beyond his research, Professor Turner actively mentors early career clinician scientists through his role at OUCAGS, teaches Oxford University medical students, and educates junior doctors and regional GPs about neurological diseases. He chairs the Case Report Podcast for Practical Neurology, demonstrating his commitment to medical education and knowledge dissemination.
He leads multiple research initiatives including the Oxford Motor Neuron Disease Centre and the FMRIB Neurodegeneration Group, collaborating with researchers like Alexander Thompson, Kevin Talbot, and Charlotte Stagg. His work bridges basic science and clinical application, with the ultimate goal of improving diagnosis, prognosis, and treatment for patients with ALS and related disorders.
